Skip to content

Clinical trials

Hypertension trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Portugal Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20081
20101
20141
20153
20182
20194
20201
20213
20222
20231
20241
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting6
Unknown status4
Not yet recruiting3
Terminated2
Enrolling by invitation2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv2
Boehringer Ingelheim2
United Therapeutics2
Universidade Nova de Lisboa2
Universidade do Porto2
University Institute of Maia2
Academia Cuf Descobertas1
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Alnylam Pharmaceuticals1
Ana Rita Londral1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension34
Cardiovascular Diseases7
Diabetes Mellitus, Type 24
Dyslipidemias4
Essential Hypertension3
Obesity3
Pulmonary Arterial Hypertension3
Sleep Apnea, Obstructive3
Stroke3
Connective Tissue Diseases2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.